Delivery Order SPE2DB22D1017-SPE2DB25FF9XK

Award Date 4/11/25
Potential Completion Date 5/2/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,100.15 and a period of performance through May 8, 2025. It is not designated as a set-aside contract, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The $1,570.70 firm fixed-price contract has an ultimate completion date of April 29, 2025 and is not set aside. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a $1,100.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Pfizer COVID-19 vaccine doses to support healthcare requirements from 2024 to 2025, including an initial 6-month period and up to a 4-year extension. This order is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The contract has a ceiling value of $1,570.70 and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $1,622.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the procurement of Pfizer COVID-19 vaccines, with a period of performance from January 2024 to January 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,100.15 and a period of performance through May 29, 2025. This contract is not designated as a set-aside and represents an open competition award. The delivery order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical products. The $11,357.70 firm fixed-price contract has an ultimate completion date of October 10, 2024. The award is likely part of a larger indefinite delivery contract the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, with an ultimate completion date of February 18, 2025. The contract is designated as Firm Fixed Price and does not have a set-aside requirement. This delivery order...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,129.80 and a period of performance ending on March 18, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9XK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The $1,100.15 firm fixed-price contract has an ultimate completion date of May 2, 2025 and is not designated as a set-aside. The contract represents a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally.

Generated 7/11/25, 9:53 AM